Abstract
Darbepoetin alfa is a biopharmaceutical glycoprotein that stimulates erythropoiesis and is used to treat anemia, which associated with renal failure and cancer chemotherapy. We herein describe the structural characterization of recombinant darbepoetin alfa produced by Leishmania tarentolae T7-TR host. The DNA expression cassette was integrated into the L. tarentolae genome through homologous recombination. Transformed clones were selected by antibiotic resistance, diagnostic PCRs, and protein expression analysis. The structure of recombinant darbepoetin alfa was analyzed by isoelectric focusing, ultraviolet–visible spectrum, and circular dichroism (CD) spectroscopy. Expression analysis showed the presence of a protein band at 40 kDa, and its expression level was 51.2 mg/ml of culture medium. Darbepoetin alfa have 5 isoforms with varying degree of sialylation. The UV absorption and CD spectra were analogous to original drug (Aranesp), which confirmed that the produced protein was darbepoetin alfa. Potency test results revealed that the purified protein was biologically active. In brief, the structural and biological characteristics of expressed darbepoetin alfa were very similar to Aranesp which has been normally expressed in CHO. Our data also suggest that produced protein has potential to be developed for clinical use.
Similar content being viewed by others
References
Jeong, T. H., Son, Y. J., Ryu, H. B., Koo, B. K., Jeong, S. M., Hoang, P., et al. (2014). Soluble expression and partial purification of recombinant human erythropoietin from E. coli. Protein Expression and Purification, 95, 211–218.
Markham, A., & Bryson, H. M. (1995). Epoetin alfa: a review of its pharmacodynamic and pharmcokinetics properties and therapeutics use in nonrenal applications. Drugs, 49, 232–254.
Cases, A. (2003). Darbepoetin alfa: a novel erythropoiesis stimulating protein. Drugs Today, 39, 477–495.
Egrie, J. C., & Browne, J. K. (2001). Development and characterization of novel erythropoiesis stimulating protein (NESP). Nephrology Dialysis Transplantation, 16, 3–13.
Egrie, J., & Browne, J. (2002). Darbepoetin alfa is more potent in vivo and can be adminstered less frequently than rHuEPO. British Journal of Cancer, 87, 476–477.
Ross, S. D., Allen, I. E., Henry, D. H., Seaman, C., Sercus, B., & Goodnough, L. T. (2006). Clinical benefits and risks associated with epoetin and darbepoetin in patients with chemotherapy-induced anemia: a systemic review of the literature. Clinical Therapeutics, 28, 801–831.
Shukurov, R. R., Lobanova, N. V., Savinova, I. N., Vorobyova, I. G., Nurbakov, A. A., Ermolina, L. V., et al. (2014). Design of a stable cell line producing recombinant darbepoetin alpha based on CHO cells. Applied Biochemistry and Microbiology, 50, 812–818.
Smith, R. (2002). Applications of darbepoietin alpha, a novel erythropoiesis stimulating protein in oncology. Current Opinion in Hematology, 9, 228–233.
Basile, G., & Peticca, M. (2009). Recombinant protein expression in Leishmania tarentolae. Molecular Biotechnology, 43, 273–278.
Breitling, R., Kingner, S., Callewaert, N., Pietrucha, R., Geyer, A., Ehrlich, G., et al. (2002). Non-pathogenic trypanosomatid protozoa as a platform for protein research and production. Protein Expression and Purification, 25, 209–218.
Fritsche, C., Sitz, M., Weiland, N., Breitling, R., & Pohl, H. D. (2007). Characterization of growth behavior of Leishmania tarentolae: a new expression system for recombinant proteins. Journal of Basic Microbiology, 45, 384–393.
Gorgensen, M. L., Friis, N. A., Just, J., Madsen, P., Petersen, S. V., & Kristensen, P. (2014). Expression of single-chain variable fragments fused with the Fc-region of rabbit IgG in Leishmania tarentolae. Microbial Cell Factories, 13, 1–9.
Davoudi, N., Hemmati, A., Khodayari, Z., Adeli, A., & Hemayatkar, M. (2011). Cloning and expression of human IFN-γ in Leishmania tarentolae. World Journal of Microbiology and Biotechnology, 27, 1893–1899.
Kovtun, O., Mureev, S., Johnston, W., & Alexandrov, K. (2010). Towards the construction of expressed proteomes using a Leishmania tarentolae based cell-free expression system. PLos One, 5, 143–148.
Kushnir, S., Cirstea, I. C., Basiliya, L., Lupilova, N., Breitling, R., & Alexandrov, K. (2011). Artificial linear episome-based protein expression system for protozoon Leishmania tarentolae. Molecular & Biochemical Parasitology, 176, 69–79.
Sambrook, J., Fritsch, E. F., & Maniatis, T. (1994). Molecular Cloning: a laboratory manual (2nd ed., pp. 1847–1857). Cold Spring Harbor: Cold Spring Harbor Laboratory press.
Feriani, M., De Meester, J. M. J., McMahon, L. P., Rottembourg, J. B., Bridges, I., Farouk, M., & Pronai, W. (2011). Extended dosing of darbepoetin alfa in peritoneal dialysis patients. BMC Nehprology, 12, 1–8.
Macdougall, I. C. (2008). Novel erythropoiesis-stimulating agents: a new era in anemia management. Journal of American Society of Nephrology, 3, 200–207.
Niimi, T. (2012). Recombinant protein production in the eukarytoic protozoan parasite Leishmania tarentolae: a review. Methods of Molecular Biology, 824, 307–315.
Phan, H. P., Sugino, M., & Niimi, T. (2009). The production of recombinant human laminin-332 in a Leishmania tarentolae expression system. Protein Expression and Purification, 68, 79–84.
Mirzaahamadi, S., Assadi-Tehrani, G., Bandehpour, M., Davoudi, N., Tahmasbi, L., Hosseinzadeh, N., et al. (2011). Expression of recombinant human coagulation factor VII by the lizard Leishmania expression system. Journal of Biomedicine and Biotechnology, 4, 1–8.
Kianmehr, A., Golavar, R., Rouintan, M., Mahrooz, A., Fard-Esfahani, P., Oladnabi, M., et al. (2016). Cloning and expression of codon-optimized recombinant darbepoetin alfa in Leishmania tarentolae T7-TR. Protein Expression and Purification, 118, 120–125.
Acknowledgments
This project was financially supported by Department of Research & Technology, Golestan University of Medical Sciences, Gorgan, Iran. The authors also wish to express their deep gratitude to all who provided support, especially Enzyme technology lab., Metabolic and Genetic Research Group, Pasteur Institute of Iran.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Ethical Statement
This article does not contain any studies with human participants performed by any of the authors.
Human and Animal Rights
All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.
Additional information
Anvarsadat Kianmehr and Abdolkarim Mahrooz contributed equally to this work.
Rights and permissions
About this article
Cite this article
Kianmehr, A., Mahrooz, A., Oladnabi, M. et al. Purification and Characterization of Recombinant Darbepoetin Alfa from Leishmania tarentolae . Mol Biotechnol 58, 566–572 (2016). https://doi.org/10.1007/s12033-016-9954-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12033-016-9954-x